insights_auto
Why is NXTCL down 9.37%?
Dive Deeperchevron_right
NXTCL:STO
NextCell Pharma AB
SEK 0.22
arrow_downward
-9.37%(-0.022) 1D
11-р сарын 20, 17:00:00 (GMT+1) · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NXTCL...
Open
SEK 0.24
High
SEK 0.24
Low
SEK 0.20
Mkt. cap
27.49 сая
Avg. vol.
1.00 сая
Volume
1.44 сая
52-wk high
SEK 1.78
52-wk low
SEK 0.20
EPS
-SEK 0.45
Shares outstanding
111.39 сая
No. of employees
21
Open
SEK 0.24
High
SEK 0.24
Low
SEK 0.20
Mkt. cap
27.49 сая
Avg. vol.
1.00 сая
Volume
1.44 сая
52-wk high
SEK 1.78
52-wk low
SEK 0.20
EPS
-SEK 0.45
Shares outstanding
111.39 сая
No. of employees
21
News stories
From web sources and news partners
Финам
·
1 өдрийн өмнө
Паника на биржах США – индекс Nasdaq упал на 5%, S&P 500 и Dow Jones перешли в фазу коррекции
БКС Экспресс
·
3 өдрийн өмнө
О сильных трендах в S&P 500, Brent, Gold, NG и TTF
FOREX.com
·
23 минутын өмнө
S&P 500, Nasdaq 100 Drive into Correction Territory
The Motley Fool
·
4 цагийн өмнө
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
Profile
NextCell Pharma AB is a Swedish biopharmaceutical company headquartered in Huddinge, in the Flemingsberg life-science cluster south of Stockholm. The company develops allogeneic mesenchymal stromal cell therapies, with its lead candidate aimed at preserving insulin production in newly diagnosed type 1 diabetes. Alongside its drug development programme, NextCell operates a private umbilical cord stem cell bank and a contract manufacturing and analytical services subsidiary for Advanced Therapy Medicinal Products. NextCell's shares trade on the Nasdaq First North Growth Market in Stockholm under the ticker NXTCL. Wikipedia
About NextCell Pharma AB
CEOMathias Svahn
Employees21
Founded2014 оны 3-р сарын 19
Headquarters-
SectorHealth Care
Industry-
Websitenextcellpharma.com